The Enterprise Value as of November 2024 (TTM) for Lipocine Inc. (LPCN) is 23.80M

According to Lipocine Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 23.80M. This represents a change of 4.54% compared to the average of 22.77M of the last 4 quarters.

Lipocine Inc. (LPCN) Historical Enterprise Value (quarterly & annually)

How has LPCN Enterprise Value performed in the past?

The mean historical Enterprise Value of Lipocine Inc. over the last ten years is 55.26M. The current 23.80M Enterprise Value has changed 4.21% with respect to the historical average. Over the past ten years (40 quarters), LPCN's Enterprise Value was at its highest in in the December 2015 quarter at 216.22M. The Enterprise Value was at its lowest in in the December 2019 quarter at 9.22M.

Lipocine Inc. (LPCN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Lipocine Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lipocine Inc. (LPCN) Average Enterprise Value

How has LPCN Enterprise Value performed in the past?

The current Enterprise Value of Lipocine Inc. (LPCN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Lipocine Inc. (LPCN) Enterprise Value vs. Peers

How is LPCN’s Enterprise Value compared to its peers?

Lipocine Inc.’s Enterprise Value is less than Sigilon Therapeutics, Inc. (42.21M), less than Reviva Pharmaceuticals Holdings, Inc. (33.37M), greater than ZyVersa Therapeutics, Inc. (2.53M), greater than Kiromic BioPharma, Inc. (13.48M), greater than Unicycive Therapeutics, Inc. (23.47M), less than Checkpoint Therapeutics, Inc. (175.79M), greater than Mustang Bio, Inc. (7.08M), less than Fortress Biotech, Inc. (57.12M), less than Kodiak Sciences Inc. (201.31M), less than Ardelyx, Inc. (1.31B), greater than Zura Bio Limited (-9969663.00), greater than Hepion Pharmaceuticals, Inc. (5.35M), greater than AVROBIO, Inc. (-85302404.00), less than Verastem, Inc. (106.15M), less than Reviva Pharmaceuticals Holdings, Inc. (0), less than Eyenovia, Inc. (33.37M), greater than Cognition Therapeutics, Inc. (15.12M), greater than TransCode Therapeutics, Inc. (-3660923.00), greater than null (4.92M),

Build a custom stock screener for Lipocine Inc. (LPCN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lipocine Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lipocine Inc. (LPCN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lipocine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.